$AKRO to present preliminary topline week 96 results from the Phase 2b SYMMETRY study investigating #EFX in patients with compensated cirrhosis (F4) due to #MASH on Monday at 8:00 AM ET:Register for the presentation here:
#AKRO #EFX #MASH